Related Experiment Video
Updated: Aug 6, 2026
14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Modulation of Nr-13 antideath activity by peptide aptamers
A-L Nouvion1, J Thibaut, O D Lohez
1Equipe Apoptose et Oncogenèse, Institut de Biologie et Chimie des Protéines (IBCP UMR 5086 CNRS/Université claude Bernard Lyon 1), IFR128 BioSciences Lyon-Gerland, Lyon, France.
Oncogene
|August 16, 2006
Summary
Researchers developed peptide aptamers targeting Nr-13, a Bcl-2 protein, to combat chemoresistant tumors. These aptamers show potential in regulating Nr-13 and inducing cancer cell death, offering new anticancer therapeutic strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Drug Discovery
Background:
- Tumor cells exhibit uncontrolled proliferation and resistance to apoptosis.
- Overexpression of Bcl-2 family antiapoptotic proteins is common in chemoresistant cancers.
- Inhibiting these proteins may sensitize cancer cells to chemotherapy.
Purpose of the Study:
- To investigate peptide aptamers as regulators of Nr-13, a Bcl-2 antiapoptotic protein.
- To explore the potential of these aptamers in sensitizing cancer cells to chemotherapy.
- To develop novel anticancer molecules targeting the Bcl-2 family.
Main Methods:
- Utilized peptide aptamer strategy to target Nr-13.
- Isolated and characterized peptide aptamers in vitro and in cultured mammalian cells.
- Assessed the regulatory and proapoptotic activities of isolated aptamers.
Main Results:
- Successfully isolated peptide aptamers that regulate Nr-13 activity.
- Demonstrated that some aptamers possess potential proapoptotic effects.
- Confirmed the efficacy of aptamers in both in vitro and cell culture models.
Conclusions:
- Peptide aptamers targeting Nr-13 can modulate its function.
- Targeting Bcl-2 family proteins with aptamers shows promise for cancer therapy.
- These findings support the development of novel anticancer agents based on peptide aptamers.
